[3/22 ±Û·Î¹ú Áõ½Ã]

DOW -0.23%, S&P-0.09%³ª½º´Ú +0.27%,

À¯·Î½ºÅ¹50 +0.08%, ¿µ±¹+0.13%, µ¶ÀÏ+0.42%, ÇÁ¶û½º +0.09%,

º§±â¿¡+0.17% ÀÌÅ»¸®¾Æ-1.9%, ÅÍÅ°-1.96%, ·¯½Ã¾Æ+0.78%

MSCI Çѱ¹ À妽ºÆݵå ETF :+0.61%

¢º º§±â¿¡ ºê·ò¼¿ Å×·¯·Î ±Þ¶ôÃâ¹ßÇÑ À¯·ÎÁõ½Ã´Â »ó½Â¹ÝÀü, ¹Ì±¹µµ °°Àº ¿òÁ÷ÀÓÀ¸·Î »ó½Â¹ÝÀüÇϱ⵵ ÇßÀ¸³ª ÈÄÀå Ç϶ôÀ¸·Î Àüȯ.

¢º ÀüÀÏ ÀϺ» ±â¼úÀû ¹ÝµîÇÏ¿´À¸³ª ¿£°­¼¼+¼öÃâºÎÁø+ÁöÇ¥¾ÇÈ­·Î ¿ÜÀÎÀÚ±Ý ÀÌÅ»¼¼ Áö¼Ó(¿£È­Åõ±âÀû ¸Å¼ö/Áֽĸŵµ º´Çà)

¢ºÁß±¹ ÀüÀÏ ±â¼úÀû Á¶Á¤À¸·Î 3õ¼± ´Ù½Ã ÀÌÅ»ÇÏ¿´À¸³ª, ±Ý³â³» ¼±°­Åë ½ÃÇà, IPOµî·ÏÁ¦ ¿¬±â, 5¿ù¸» MSCI AÁÖ 1/2 Ãß°¡ÆíÀÔ, MSCI ¿¬³» À̸Ó¡¼±ÁøÁö¼ö ÆíÀÔ ±â´ë·Î ¼ô¼¼·ÂÀÌ °ø°ÝÁßÁöÇÑ »óÅ·ΠÇϹæ°æÁ÷ÀÌ °­ÇÑ »óÅ 

¿øÀÚÀç

WTI 41.45$(-0.17%) ºê·»Æ®41.81$(+0.65%), µÎ¹ÙÀÌ37.43$(+0.78%),

±Ý+0.35%, ±¸¸®+0.27%, ¾Ë·ç¹Ì´½-0.76%, ´ÏÄÌ+0.83%, ¾Æ¿¬-0.04%, ÁÖ¼®+1.1%

¢ºÅ×·¯·Î ÀÎÇØ ¾ÈÀüÀÚ»ê ¼±È£È帧 ³ª¿À¸ç ±Ý ±Þµî, ¿øÀ¯ ±Þ¶ôÇÏ´Ù°¡ »ó´çºÐ µÇµ¹¸² ³ª¿À¸çµî¶ô °ÅµìÇϴ٠ȥÁ¶¼¼ ¸¶°¨.

DXY 95.66(+0.26%Àý»ó), ´Þ¶ó/À¯·ÎÈ­(-0.30% ÀýÇÏ), ´Þ¶ó/ÆÄ¿îµå(-1.02%ÀýÇÏ)

¿ø´Þ·¯ 1153.60(0.85%Àý»ó) , ¿£´Þ·¯ 111.71(0.07% ÀýÇÏ), À§¾È´Þ¶ó 6.488(0.11%ÀýÇÏ)

¢º Å×·¯¿µÇâ°ú ÀÌ·ÎÀÎÇÑ ºê·º½ÃÆ® °¡´É¼º °íÁ¶µÇ¸ç ÆÄ¿îµå, À¯·ÎÈ­ ±Þ¶ô »ó´ëÅëÈ­ÀÎ ¹Ì´Þ¶ó´Â µû¶ó¼­ »ó´ëÀû °­¼¼.  

NYSE ¾÷Á¾º°

»ý¸í°øÇÐ/ÇｺÄÉ¾î ¼½Å¸ ±º°èÀÏÇÐ >ºñö±Ý¼Ó>ÀÚµ¿Â÷>Ä«Áö³ë>°Ç¼³.>ö°­ »ó½Â

¿î¼Û,Ç×°ø,¿©Çà, ¼÷¹Ú>Áõ±Ç.±ÝÀ¶>º¸Çè>À½½Ä·áµî ¼ÒºñÀç>¿øÀ¯> ¼Ò¸Å ¼øÀ¸·Î Ç϶ô(Å×·¯¿µÇâ)

»ó½ÂÁ¾¸ñ: ¾ÏÁ¨, È­ÀÌÀÚ, ¹ÙÀÌ¿ÀÁ¨, ¾Æ¸¶Á¸, ¾ÖÇÃ, M/S, ½Ã½ºÄÚ,¿¢¼Õ¸ðºô »ó½Â

Ç϶ôÁ¾¸ñ: °ñµå¸¸,JP¸ð°£, º¸À×,µàÆþ, P&G, À̺£ÀÌ µî 

Á¦¾à/ÇｺÄÉ¾î °ü·ÃÁö¼ö

S&PÇｺÄɾî(+0.89%, S&P³» À¯ÀÏ»ó½Â), ³ª½º´Ú»ý¸í°øÇÐ(+2.61%), ¾Æ¸ß½º»ý¸í(+2.71%)

ETF: IBB(+2.58%), XBI(3.27%), XPH(+4.02%)

¢º ÇｺÄɾî Á¦¾à¼½Å¸´Â ±Ý³âµé¾î ¼±Áø/À̸Ó¡  ¾ç½ÃÀå¿¡¼­ Æݵå¼øÀ¯ÃâÀÌ °¡Àå ÄÇ´ø À¯ÀÏÇÑ ¼½ÅͷΠ Ãֱ٠ij³ª´Ù Á¦¾à»ç ¶óÀ̼¾½ºÀÎ À¸·Î ÀÎÇÑ  ÀÚº»Àá½Ä ºÎ½Ç ¿ì·Á µîµµ ±¹³» L/O ±â´ë Á¦¾à»çµé¿¡°Ô  ½É¸®Àû ºÒ¾È°¨À¸·Î ÀÛ¿ëÇϱ⵵ ÇÏ¿´À¸³ª  µ¿¼½Å¸ P/E  Ratio°¡  ÀÌ¹Ì S&P Æò±ÕÀ»  ÇÏȸÇÏ´Â µî ±Ø½ÉÇÑ ÀúÆò°¡ ±¹¸é.  ÀÌ¿¡ µû¸¥ ±â¼úÀû ¹Ýµî ±¹¸é ±â´ë ¹×  ÃßÁ¾ ¼½Å¸  ±Û·Î¹ú ÃßÁ¾¸Å¸Å ±â´ë.

¢ºÂü°í·Î ETF ±¸¼ºÁ¾¸ñÀ» º¸¸é,

IBB(2/29 ±âÁØ) Biogen(9.53%), Amgen(9.49%), Celgene(9.17%), Gilead Science(7.84%), Regenero( 7.38%), Mylan (4.62%), Illumina(4.13%), Alexion Pharmaceuticals(4.09%), Vertex Pharmaceuticals Incorpor (3.51%), Incyte Corporation(2.34%). ÀÌ»ó 10°³»ç 62.1% ±¸¼º

XBI: ±¸¼ºÁ¾¸ñ Top 10 (2016.2/29) Baxalta [BXLT] 2.19%, I ntrexon Corporation [XON] 2.14%, AbbVie [ABBV] 2.08% Amgen [AMGN] 1.98%, Celgene [CELG] 1.97%, Cepheid [CPHD] 1.93%, PTC Therapeutics [PTCT] 1.91%, Biogen [BIIB] 1,89%, AMAG Pharmaceuticals [AMAG] 1.87%, Gilead Sciences [GILD] 1.83% 10°³»ç ÇÕ°è 19.79% ÀÌ¿Ü Áß¼ÒÇü ¹ÙÀÌ¿ÀÅ×Å©»ç ´Ù¼ö·Î ±¸¼º  

 XPHSPDR S&P Pharmaceuticals ETF:±¸¼ºÁ¾¸ñ Top 10 MRK Merck 4.26% , LLY Eli Lilly 4.25% , AGN Allergan plc 4.25%, PRGO Perrigo 4.24% , JNJ Johnson &Johnson 4.17% , PFE Pfizer 4.16%, MYL Mylan NV 4.14% , ZTS Zoetis 4.13% , ENDP Endo 4.06% , BMY Bristol-Myers 4.03%, SPDR S&P Pharmaceuticals ETF

±ÝÀÏ °ü½ÉÁöÇ¥: ´Þ¶ó, ÆÄ¿îµåÈ­, ¿£È­°­¼¼(¿øÈ­µµ °­¼¼ ¿©ºÎ)

À¯°¡, ±Ý, ±¸¸®(Åõ±âÀû¼¼·Â ¼ôÄ¿¹ö Áö¼Ó¿©ºÎ)

ÃÖ±Ù À¯°¡ ±ÞµîÀ¸·Î »óÇ°°¡°Ý »ó½Â ±â´ë·Î ÀÎÇÏ¿©2016³â ½ÇÀû ÄÁ¼¾¼­½º´Â »óÇâÁ¶Á¤µÇ°í ÀÖÀ¸³ª( Á¤À¯, ÇｺÄɾî, µð½ºÇ÷¹ÀÌ µî), ÇöÀç 12FW  PER 11.1¹è·Î ÃÖ±Ù ÄÚ½ºÇÇÁö¼öÀÇ »ó½Â·ü ÀûÁ¤¼º ¿©ºÎ.  

113